Hisamitsu Pharma

39.12 <%= Resources.Global.txtUp %>
Updated 19/09/2019
Change % 0.58% Stock price increasing
Change 0.225 Stock price increasing
Volume 0
High 39.12
Low 39.12
Open 39.12
ISIN JP3784600003
Prev close 38.90
# of shares 95.16M
Market cap 3,722.85M EUR

Market closed
Hisamitsu Pharma
Market is closed, opens at 08:00
Price development Latest 1 week 1 month 3 months 6 months 1 year
  39.12 -0.6% Stock price decreasing 10.9% Stock price increasing 15.5% Stock price increasing 1.9% Stock price increasing -38.9% Stock price decreasing
Powered by TradingView

Company profile

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
22 September 2019 07:39:35
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190829.2 - EUROWEB3 - 2019-09-22 08:39:35 - 2019-09-22 07:39:35 - 1000 - Website: OKAY